Quick Answer
FENNEC PHARMACEUTICALS INC. reported Cash And Cash Equivalents At Carrying Value of $36.79 million for the year ending 2025.
- FENNEC PHARMACEUTICALS INC. showed an increase of +38.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 1996 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $36.79 million | Fiscal year 2024: $26.63 million | Fiscal year 2023: $13.27 million | Fiscal year 2022: $23.77 million | Fiscal year 2021: $21.10 million | Fiscal year 2020: $30.34 million | Fiscal year 2019: $13.65 million | Fiscal year 2018: $22.78 million | Fiscal year 2017: $28.26 million | Fiscal year 2016: $3.93 million | Fiscal year 2015: $942.0 thousand | Fiscal year 2014: $2.31 million | Fiscal year 2013: $1.66 million | Fiscal year 2012: $2.30 million | Fiscal year 2011: $5.30 million | Fiscal year 2010: $5.95 million | Fiscal year 2009: $685.0 thousand | Fiscal year 1996: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: